Xin Xu

Xin Xu


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2023 in International Journal of Surgery
Verified
Journal Article
Open access
WTWeiliang Tian
Weiliang Tian
XXXin Xu
Xin Xu
RZRisheng Zhao
Risheng Zhao
GZGuoping Zhao
Guoping Zhao
WLWuhan Li
Wuhan Li
ZYZheng Yao
Zheng Yao
Background: In patients diagnosed with sarcopenia, the presence of chronic preoperative inflammation, assessed by the ratio of the visceral fat area (VFA) to the total abdominal muscle area index (TAMAI) (VFA/TAMAI), has been found to adversely affect wound healing. An elevated VFA/TAMAI may contribute to a higher incidence of postoperative recurrent fistulas (RFs) following definitive surgery (DS) for small intestinal fistulas accompanied by diffuse extensive abdominal adhesions. The objective of this study was to evaluate the predictive value of VFA/TAMAI for postoperative RFs. Methods: The study enrolled 183 sarcopenic patients, with a median age of 51 years [interquartile range (IQR): 38–61 years), a median body mass index of 19.6 kg/m2 (IQR: 18.9–21.0 kg/m2) who underwent DS for small intestinal fistulas between January 2018 and October 2022 were included in the multicenter study. The outcomes assessed were RFs and postoperative length of stay (LOS). VFA/TAMAI was examined as a potential risk factor for each outcome. Results: Out of the 183 patients, 20.2% (n=37) developed RFs. The multivariate regression analysis identified VFA/TAMAI as the sole factor associated with RFs [odds ratio=1.78, 95% confidence interval (CI): 1.09–2.87, P=0.02]. The multivariable Cox regression analysis demonstrated that an elevated VFA/TAMAI was linked to a reduced postoperative LOS (hazard ratio=0.69, 95% CI: 0.59–0.81, P<0.001). Conclusion: In sarcopenic patients, a high VFA/TAMAI predicated the occurrence of RFs after DS for small intestinal fistulas in the presence of diffuse extensive abdominal adhesions.

29 May 2024 in International Journal of Surgery
Verified
Journal Article
Open access
WTWeiliang Tian
Weiliang Tian
LLLei Luo
Lei Luo
XXXin Xu
Xin Xu
RZRisheng Zhao
Risheng Zhao
TTTao Tian
Tao Tian
ZYZheng Yao
Zheng Yao
Background: This study was designed to develop and validate a nomogram for predicting intolerable early enteral nutrition (EEN) following definitive surgery (DS) for small intestinal fistula. Methods: A total of 377 patients, recruited from January 2016 to September 2023, was randomly allocated into development (n=251) and validation (n=126) groups in a 2:1 ratio. Risk factors were identified using the nomogram. Its performance was assessed based on calibration, discrimination, and clinical utility, with validation confirming its effectiveness. Results: Of the 377 patients, 87 (23.1%) were intolerant to EEN, including 59 (23.1%) in the development cohort and 28 (22.1%) in the validation cohort (P=0.84). Four factors were identified as predictive of intolerable EEN: severe abdominal adhesion, deciliter of blood loss during DS, human serum albumin (Alb) input >40 g during and within 48 h post-DS, and the visceral fat area (VFA)/total abdominal muscle area index (TAMAI) ratio. The model demonstrated excellent discrimination, with a C-index of 0.79 (95% CI: 0.74–0.87, including internal validation) and robust calibration. In the validation cohort, the nomogram showed strong discrimination (C-index=0.77; 95% CI: 0.64–0.87) and solid calibration. Decision curve analysis affirmed the nomogram’s clinical utility. Conclusion: This research introduces a nomogram that enables the individualized prediction of intolerable EEN following DS for small intestinal fistula, demonstrating a possible clinical utility.

11 December 2025 in Frontiers in Nutrition
Verified
Journal Article
Open access
TYTianchi Yu
Tianchi Yu
XLXiaofeng Liao
Xiaofeng Liao
SLShikun Luo
Shikun Luo
XXXin Xu
Xin Xu
RZRisheng Zhao
Risheng Zhao
ZYZheng Yao
Zheng Yao
Background: To determine the correlation between the C-reactive protein-lymphocyte ratio (CLR) and the spontaneous resolution of anastomotic leakage (AL) subsequent to the resection of enterocutaneous fistulas (ECF). Methods: In this retrospective cohort analysis, we examined adult patients who experienced AL following ECF resection from January 2019 to January 2024. Observations continued for 90 days post-surgery, during which CLR values were recorded at designated intervals. The relationship between CLR and the spontaneous resolution of leakage by 30 and 90 days was evaluated using logistic regression and restricted cubic splines. Results: Out of 107 participants, 35 (32.7%) exhibited spontaneous resolution of leakage within 30 days, while 90 (84.1%) did so by the 90-day mark. A significant association was noted between CLR on day 7 post-leakage and 30-day resolution (OR = 0.97, 95%CI: 0.94–0.99, p = 0.03). Additionally, CLR on day 14 post-leakage correlated with 90-day resolution (OR = 0.88, 95%CI: 0.79–0.95, p = 0.003). A J-shaped curve was observed in the relationship between CLR levels and closure rates at both time frames. Notably, the resolution rate was considerably lower in patients whose ECF was attributable to pancreatitis, with an OR of 0.21 ( p = 0.02) relative to other causes. Conclusion: Decreasing CLR subsequent to leakage may be one of supportive predictor for spontaneous closure of AL following ECF resection.

28 October 2025 in Scientific Reports
Verified
Journal Article
Open access
WSWeiwei Shang
Weiwei Shang
WLWuhan Li
Wuhan Li
XXXin Xu
Xin Xu
RZRisheng Zhao
Risheng Zhao
ZYZheng Yao
Zheng Yao
To investigate the incidence, risk factors, and outcomes of acute acalculous cholecystitis (AAC) following prolonged gastrointestinal disuse due to external duodenal fistula. This retrospective cohort study included adult patients with external duodenal fistula who experienced gastrointestinal tract disuse from January 2018 to January 2024. Patients were monitored until discharge or death. The primary outcome was the occurrence of AAC, while secondary outcomes included its treatment and prognosis. Of the enrolled 133 patients, 59 (44.4%) were diagnosed with AAC. The majority (79.7%) of AAC cases occurred during the reintroduction of enteral nutrition (EN). High SOFA score upon admission (Odds Ratio [OR] = 1.59, 95% Confidence Interval [CI]: 1.13-2.70, p = 0.005) and the vasopressor use upon admission (OR = 4.53, 95% CI: 1.09-19.22, p = 0.04) were associated with increased risk of AAC before EN reintroduction. For AAC occurring after EN reintroduction, the duration of intestinal disuse (OR = 1.06, 95% CI: 1.00-1.13, p = 0.04) was the sole risk factor. The incidence of AAC is notably high in patients undergoing prolonged gastrointestinal tract disuse, particularly after the reintroduction of Enteral Nutrition (EN) in patients with external duodenal fistula.

19 November 2025 in BMC Surgery
Verified
Journal Article
Open access
FYFan Yang
Fan Yang
SLShikun Luo
Shikun Luo
ZHZhiwu Hong
Zhiwu Hong
WTWeiliang Tian
Weiliang Tian
GZGuoping Zhao
Guoping Zhao
ZYZheng Yao
Zheng Yao
Postoperative inflammatory ileus (PII) is characterised by long-term re-obstruction, following temporary defecation. An intestinal fistula excision (IFE) with severe abdominal adhesions could increase the risk of PII in patients with sarcopenia. On the other hand, the postoperative outcomes are negatively impacted owing to chronic preoperative inflammation, as measured by the visceral fat area (VFA) and the total abdominal muscle area index (TAMAI) ratio. This study aims to evaluate the predictability of VFA/TAMAI for postoperative PII after IFE. Four tertiary centres participated in this retrospective cohort study. Patients with sarcopenia who underwent IFE between January 2018 and October 2022 were enrolled. VFA/TAMAI was evaluated as a risk factor for PII. We included 177 eligible patients (102 [57.6%] males) with a median age of 51 years (interquartile range [IQR]: 38-61 years) in this study. PII occurred in 16.9% of patients (n = 30), with an interval of four days (IQR: 3-5 days) between IFE and temporary defecation. The duration of the re-obstruction after temporary defecation was 23 days (IQR: 21-30 days), following temporary defecation that lasted for one days (IQR: 1-2 days). The adjusted logistic regression revealed that VFA/TAMAI was associated with PII (odds ratio = 1.51, 95% confidence interval: 1.02-2.19; p = 0.03). VFA/TAMAI was associated with inflammatory ileus after IFE with severe abdominal adhesions in patients with sarcopenia.

21 September 2026 in Frontiers in Nutrition
Verified
Journal Article
Open access
PDF file
JSJingfei Sun
Jingfei Sun
XXXin Xu
Xin Xu
RZRisheng Zhao
Risheng Zhao
ZYZheng Yao
Zheng Yao
YZYunzhao Zhao
Yunzhao Zhao
QHQian Huang
Qian Huang
Background: Short bowel syndrome (SBS) type I, characterized by an end stoma without colonic continuity, poses significant challenges in fluid and electrolyte management. The defunctionalized colon remains dormant before stoma reversal, representing an untapped absorptive reserve. Percutaneous endoscopic colostomy (PEC) provides a minimally invasive route for scheduled chyme reinfusion, yet evidence regarding its nutritional benefits remains limited. This study aimed to examine whether PEC-guided colonic chyme reinfusion before stoma reversal is associated with improved nutritional outcomes in type I SBS patients with preserved colon. Methods: This retrospective cohort study included 71 type I SBS patients with retained intact colon undergoing stoma reversal between August 2019 and May 2024. Patients were divided into the PEC group (n = 57, treated after 2021) and the non-PEC historical control group (n = 14, treated before 2021). Nutritional outcomes, including serum albumin, prealbumin, C-reactive protein (CRP), body mass index (BMI), electrolyte supplementation requirements, intravenous fluid requirements, and enteral nutrition tolerance, were assessed at admission and at 2 months after admission. Linear mixed-effects models and logistic regression were used for statistical analysis. Results: Both groups showed significant improvements in most nutritional parameters over time. The PEC group demonstrated significantly greater reductions in intravenous fluid requirements (1761 vs. 3305 mL, P < 0.0001), sodium supplementation (3.91 vs. 7.63 g, P < 0.0001), and potassium supplementation (2.50 vs. 4.73 g, P < 0.0001) at 2 months. Enteral nutrition tolerance improved more substantially in the PEC group (51.2 vs. 40.0 mL/h, P < 0.0001). Prealbumin levels increased significantly more in the PEC group, with a significant time-by-group interaction ( P = 0.014). PEC-related complications occurred in 4 patients (7.0%), all Grade I or II. However, no significant between-group differences were observed in CONUT and NRS2002 scores, albumin, or BMI at the 2-month time point. Discussion: PEC-guided chyme reinfusion in type I SBS patients with a defunctionalized but intact colon was associated with reduced parenteral fluid and electrolyte requirements, improved enteral tolerance, and increased prealbumin levels within a 2-month preoperative window, with an acceptable safety profile. Global nutritional screening scores showed limited changes, suggesting that the early benefits of PEC are primarily manifested in reduced parenteral support dependence rather than broad nutritional indices. Prospective randomized trials with longer follow-up are warranted to confirm these findings.